BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1472470)

  • 1. Oncogenic transformation by Jun: role of transactivation and homodimerization.
    Hartl M; Vogt PK
    Cell Growth Differ; 1992 Dec; 3(12):899-908. PubMed ID: 1472470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric c-Jun containing an heterologous homodimerization domain transforms primary chick embryo fibroblasts.
    Castellazzi M; Loiseau L; Piu F; Sergeant A
    Oncogene; 1993 May; 8(5):1149-60. PubMed ID: 8479740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
    Hughes M; Sehgal A; Hadman M; Bos T
    Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation.
    Nishizawa M; Fu SL; Kataoka K; Vogt PK
    Oncogene; 2003 Sep; 22(39):7931-41. PubMed ID: 12970741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased transforming activity of JunB and JunD by introduction of an heterologous homodimerization domain.
    Vandel L; Pfarr CM; Huguier S; Loiseau L; Sergeant A; Castellazzi M
    Oncogene; 1995 Feb; 10(3):495-507. PubMed ID: 7845674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rearranged junD transforms chicken embryo fibroblasts.
    Hartl M; Vogt PK
    Cell Growth Differ; 1992 Dec; 3(12):909-18. PubMed ID: 1472471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
    Morgan IM; Asano M; Håvarstein LS; Ishikawa H; Hiiragi T; Ito Y; Vogt PK
    Oncogene; 1993 May; 8(5):1135-40. PubMed ID: 8479738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J; Briggs J; Findlay C; Bos T
    Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
    Bost F; Caron L; Vial E; Montreau N; Marchetti I; Dejong V; Defize L; Castellazzi M; Binétruy B
    Oncogene; 2001 Nov; 20(50):7425-9. PubMed ID: 11704873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S; Brown PH; Birrer MJ
    Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
    Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
    Blazek E; Wasmer S; Kruse U; Aronheim A; Aoki M; Vogt PK
    Oncogene; 2003 Apr; 22(14):2151-9. PubMed ID: 12687017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun.
    Oehler T; Pintzas A; Stumm S; Darling A; Gillespie D; Angel P
    Oncogene; 1993 May; 8(5):1141-7. PubMed ID: 8479739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
    Schuur ER; Parker EJ; Vogt PK
    Cell Growth Differ; 1993 Sep; 4(9):761-8. PubMed ID: 8241024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cellular transformation by glucocorticoid receptor mutants.
    Kameda T; Iba H
    Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S; Vial E; van Dam H; Castellazzi M
    Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jun, the oncoprotein.
    Vogt PK
    Oncogene; 2001 Apr; 20(19):2365-77. PubMed ID: 11402333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.